ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma

Journal of Surgical Research

Volumn 60, Issue 2, 1996, Pages 398-402

  Burno, Derrick K ^a   Fabian, Dagmar F ^a   Lefor, Alan T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; INTERCELLULAR ADHESION MOLECULE 1; NEOMYCIN;

ANIMAL CELL; CELL ADHESION; CHROMIUM 51 RELEASE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FIBROSARCOMA; GENETIC TRANSFECTION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; UMBILICAL VEIN;

EID: 0030064072     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0065     Document Type: Conference Paper

References (13)

1. Lefor, A. T., Foster, C. E., Sartor, W., Engbrecht, B., Fabian, D. F., and Silverman, D. Hyperthermia increases ICAM-1 expression and lymphocyte adhesion to endothelial cells. Surgery 116: 214-221, 1994.
2. Sartor, W. M., Kyprianou, N., Fabian, D. F., and Lefor, A. T. Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate. J. Surg. Res. 59: 66-74, 1995.
3. Burno, D. K., Kyprianou, N., Sartor, W. M., Fabian, D. F., Turner, J., Vu, T., Patel, A., Trimbach, C., and Lefor, A. T. Transfection of a murine fibrosarcoma with ICAM-1 enhances the response to adoptive immunotherapy. Surgery 118, 237-244, 1995.
4. Van Seventer, G. A., Shimizu, Y., Horgan, K. J., and Shaw, S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144: 4579-4586, 1990.
5. Lefor, A. T., Steinberg, S. M., and Wiebke, E. A. Analysis of chromium-51 release assay data using personal computer spreadsheet software. Comp. Biomed. Res. 21: 268-275, 1988.
6. Altmann, D. M., Hogg, N., Trowsdale, J., and Wilkinson, D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen presenting cell function in mouse L cells. Nature 338: 512-514, 1989.
7. - melanoma cells are relatively resistant to CD3-mediated T-cell lysis. Int. J. Cancer 46: 475-480, 1990.
8. Xu, H., Tong, I. L., De Fougerolles, A. R., and Springer, T. A. Isolation, characterization, and expression of mouse ICAM-2 complementary and genomic DNA. J. Immunol. 149: 2650-2655, 1992.
9. Johnston, S. C., Dustin, M. L., Hibbs, M. L., and Springer, T. A. On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. J. Immunol. 145: 1181-1187, 1990.
10. Naganuma, H., Kiessling, R., Patarroyo, M., Hansson, M., Handgretinger, R., and Grönberg, A. Increased susceptibility of IFN-γ-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: Participation of ICAM-1 induction on target cells. Int. J. Cancer 47: 527-532, 1991.
11. Pandolfi, F., Trentin, L., Boyle, L. A., Stamenkovic, I., Byers, H. R., Colvin, R. B., and Kurnick, J. T. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer 69: 1165-1173, 1992.
12. Quillet-Mary, A., Cavarec, L., Kermarrec, N., Marchiol-Fournigault, C., Gil, M. L., Conjeaud, H., and Fradelizi, D. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets. Int. J. Cancer 47: 473-479, 1991.
13. Freeman, S. M., Abboud, C. N., Whartenby, K A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53: 5274-5283, 1993.